{"title":"Transdermal Delivery of Ondansetron Hydrochloride in the management of Hyperemesis Gravidarum","authors":"Snigdha Bhardwaj, Sonam Bhatia, Shaminder Singh","doi":"10.21817/ijpsr/2020/v11i8/201108004","DOIUrl":"https://doi.org/10.21817/ijpsr/2020/v11i8/201108004","url":null,"abstract":"Transdermal route has always been a route of choice for those drugs having limitations through oral route. Transdermal delivery of Ondansetron Hydrochloride (HCl) is one of the potential strategies, capable of maximizing the drug performance in patients with Hyperemesis Gravidarum facing issues with oral drug delivery. Current study focused on the development of matrix transdermal patches of Ondansetron HCl using solvent casting method with combination of different polymers and eugenol as penetration enhancer followed by physical characterization for various parameters such as weight variation, folding endurance, moisture content, moisture uptake, drug content, tensile strength, elongation break test, FT-IR studies, in-vitro percent drug release, stability studies. The result suggested that formulation F3 exhibited optimum results in respect to physical evaluation and in-vitro drug release exhibited release in concentration independent manner (62.2±1.3% upto 8 hrs). All formulations followed zero-order kinetics and Higuchi’s model values showed ‘diffusion’ as predominant release mechanism. FT-IR analysis revealed that there are no potential chemical interactions between the drug and the polymers. Stability studies revealed promising result and the formulation (F3) was found to be stable at 40±2°C and 75±5% RH. The study indicated that transdermal delivery of Ondansetron HCl is a suitable way to increase therapeutic effectiveness.","PeriodicalId":358693,"journal":{"name":"International Journal of Pharma Sciences and Research","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134579005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In Silico Design, Synthesis and In Vitro Antidiabetic Activity of Novel 5-Furyl- 1,3,4-Thiadiazolimines","authors":"S. A. Hameed, Joyamma Varkey, P. Jayasekhar","doi":"10.21817/ijpsr/2020/v11i5/201106011","DOIUrl":"https://doi.org/10.21817/ijpsr/2020/v11i5/201106011","url":null,"abstract":"- Postprandial hyperglycemia plays an important role in the development of T2DM. The promising therapeutic approach is to decrease hyperglycemia by decreasing the postprandial rise in blood glucose concentration. In our study, a series of novel 5-furyl- 1,3,4-thiadiazol-2-imine derivatives were designed and those with good Physico-chemical properties were synthesized by oxidative cyclization between aryl acid and thiosemicarbazide using phosphorous oxychloride and subsequent treatment with aromatic aldehydes with varying substituents. Docking studies with the human pancreatic alpha-amylase enzyme in complex with myricetin (PDB ID: 4GQR) and peroxisome proliferator-activated receptor gamma (PPARgamma) (PDB ID: 1FM6) were done to predict the protein-ligand binding modes. The compounds SA07, SA03 and SA04 showed significantly high docking scores while SA01, SA05 and SA06 showed moderate scores. All derivatives were subjected to in vitro anti-diabetic screening using chromogenic dinitro salicylic acid method (α amylase inhibition assay). Significant percentages of inhibition were reported for SA03, SA07 and SA04 with acarbose as standard. Molecular docking revealed that synthesized derivatives and target proteins were actively involved in binding before and after systemic absorption and had a significant correlation with their biological activity. of the heterodimer of the retinoid X proliferator-activated receptors gamma (PPARgamma) ligand binding domains respectively bound with 9-cis retinoic and rosiglitazone and co-activator peptides retrieved from PDB with PDB with a resolution 2.1A 0 . The active site selected for the are Phe 282, Cys285, Ser289, Leu330, Met364, Tyr473, binding of","PeriodicalId":358693,"journal":{"name":"International Journal of Pharma Sciences and Research","volume":"80 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115658958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohd Aleemuddin Qumari, Farooqui Shazia Parveen, Anzar Alam, M. Ahad
{"title":"Chronology of COVID-19 Pandemic – the Un-flatten Curve","authors":"Mohd Aleemuddin Qumari, Farooqui Shazia Parveen, Anzar Alam, M. Ahad","doi":"10.21817/ijpsr/2020/v11i5/201103025","DOIUrl":"https://doi.org/10.21817/ijpsr/2020/v11i5/201103025","url":null,"abstract":"The COVID-19 pandemic gripped 193 countries including certain territories, though the disease started in Wuhan city China on 17th November 2019 as pneumonia of unknown origin linked to its seafood market, the China health authorities reported it as on 31st December 2019. The coronavirus responsible for the disease is a novel stain observed in human is a spill-over from animals seems to be bats with 96% genomic resemblance indicative of an intermediary host a mammal till not known. Initially, it has considered as human-to-human transmission of infection through contact, later hypothesizing the spread through aerosol infection also. The uncertainty with the disease has little compared with past influenza as if conditions but most of the things associates with this are unpredictable. Now, more than 2 million cases found positive with 2.5 lac cases of death around the world still it is on with meagre recovery rate. The course diseases and its management become a big task for the entire globe. The entire globe is finding the solutions with historical observations and experience, including the use of antiviral, antibiotics, and anti-malarial drugs and plasma convalescent therapy beyond these placenta proteins cells, and mesenchymal stem cell therapy are being under exploration as effective means in the management of COIVD-19.","PeriodicalId":358693,"journal":{"name":"International Journal of Pharma Sciences and Research","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126740478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Screening of Potential Candidates for SARS-CoV-2 Spike Glycoprotein using Bioinformatics approach","authors":"Dhammapal Bharne","doi":"10.21817/ijpsr/2020/v11i5/201105003","DOIUrl":"https://doi.org/10.21817/ijpsr/2020/v11i5/201105003","url":null,"abstract":"Abstract Background: Covid-19 is a pandemic disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It deceased more than three lakh people and infected millions of people across the globe till date. The disease is highly contagious, spreading from person to person through direct contact or through the aerosols released by coughing or sneezing. To reduce the chain of infections, social distancing and sanitary measures are followed. Since, drugs and vaccines are under development, screening of potential candidates using bioinformatics approach may provide an instant solution to stop further deaths and spread of the disease. Methods: Orthologous proteins of SARS-CoV-2 were predicted with reciprocal best blast hit to identify the protein with large evolutionary difference. Homologous region of the evolutionary difference in 3D structure of the proteins was detected using multiple sequence alignment (MSA). The candidates from DrugBank exhibiting high binding affinities with the homologous region as well as with the entire protein structure were uncovered through docking analysis. Results: The orthologous proteins showed the surface spike glycoprotein as the protein with large evolutionary difference. The MSA detected GLN96, LEU97, GLN98, ALA99 and LEU100 amino acid sequence in the spike glycoprotein as the homologous region of evolutionary difference. Docking analysis revealed Remdesivir and TMC_310911 to exhibit the highest binding affinities with the homologous region and the entire protein respectively. Conclusions: The present study uncovers Remdesivir and TMC_310911 as the highly potential candidates for Covid-19. Further investigations may lead to prevention of infections and mortality due to the disease.","PeriodicalId":358693,"journal":{"name":"International Journal of Pharma Sciences and Research","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117269743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}